Inventor
SALMERON GARCIA JOSE ANDRES
US13 patents
⚠️ This page may combine multiple inventors who share the name “SALMERON GARCIA JOSE ANDRES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WEREWOLF THERAPEUTICS INC
9 patentsUS10696724B2Jun 30, 2020
Activatable interleukin-2 polypeptides
WEREWOLF THERAPEUTICS INC18 citations93
US10696723B2Jun 30, 2020
Activatable interleukin 12 polypeptides
WEREWOLF THERAPEUTICS INC15 citations93
US11352403B2Jun 7, 2022
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC6 citations84
US11981716B2May 14, 2024
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC2 citations72
US11535658B2Dec 27, 2022
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC2 citations72
US12534505B2Jan 27, 2026
Activatable interleukin-2 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations61
US12275769B2Apr 15, 2025
Activatable interleukin 12 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations61
US11453710B2Sep 27, 2022
Activatable interleukin 12 polypeptides and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations61
US11739132B2Aug 29, 2023
Separation moieties and methods of use thereof
WEREWOLF THERAPEUTICS INC0 citations57
POTENZA THERAPEUTICS INC
4 patentsUS10227413B2Mar 12, 2019
Anti-neuropilin antigen-binding proteins and methods of use thereof
POTENZA THERAPEUTICS INC2 citations71
US11186644B2Nov 30, 2021
Anti-neuropilin antigen-binding proteins and methods of use thereof
POTENZA THERAPEUTICS INC1 citations61
US11453720B2Sep 27, 2022
Anti-TIGIT antigen-binding proteins and methods of use thereof
POTENZA THERAPEUTICS INC0 citations48
US10988545B2Apr 27, 2021
Anti-GITR antigen-binding proteins and methods of use thereof
POTENZA THERAPEUTICS INC0 citations47